BKYI stock news
This page provides real-time market news, earnings updates, and company announcements related to BIO-key International, Inc. (BKYI).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 20:03 EST
Avantor (AVTR) Q4 Preview: Key Information to Know Before Earnings Release
101 finance2026-02-10 03:21:37
MitoCareX Bio Reports Successful Results in Vitro: MITOLINE-Powered Small Molecules Show Anti-Inflammatory Potential for Metabolic Syndrome-Related Diseases
Finviz2026-02-12 12:30:11
Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year
Finviz2026-02-12 13:33:07
Upstream Bio's Selloff May Be 'Overdone,' But Analyst Highlights Asthma Drug's Competitive Edge Concerns
Finviz2026-02-13 15:48:11
Stocks End Modestly Up as Bond Yields Decline
101 finance2026-02-14 00:48:13
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
Finviz2026-02-18 13:48:54
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
Finviz2026-02-19 16:33:05
Sotera Health Company (SHC) Q4 Earnings Preview: Key Points to Watch
101 finance2026-02-23 03:12:38
Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026
Finviz2026-02-23 13:42:48
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
Finviz2026-02-23 22:15:05
Qualcomm, Booking Holdings receive upgrades: Leading analyst picks from Wall Street
101 finance2026-02-24 14:45:35
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
Finviz2026-02-24 17:33:10
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 21:33:11
Gossamer Bio (GOSS) Reports Topline Phase 3 Results for Seralutinib in Pulmonary Arterial Hypertension
Finviz2026-02-25 10:54:06
Darling Ingredients (NYSE:DAR) Q4 Results: Outperforming in the Ingredients, Flavors & Fragrances Sector
101 finance2026-02-25 13:03:42
N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
Finviz2026-02-25 13:34:28
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
Finviz2026-02-25 13:48:47
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Finviz2026-02-26 12:03:47
Regenxbio (RGNX) Likely to Surpass Earnings Predictions: Will the Share Price Rise?
101 finance2026-02-26 16:04:08
Keros Therapeutics Appoints Charles Newton to its Board of Directors
Finviz2026-02-26 21:03:45
Nexa Resources Reports Adjusted EBITDA of US$772 Million, and US$223 Million Net Income in 2025
Finviz2026-02-26 21:27:03
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
Finviz2026-02-27 19:24:07
Stocks End Modestly Up as Bond Yields Decline
101 finance2026-02-14 00:48:13
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
Finviz2026-02-18 13:48:54
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
Finviz2026-02-19 16:33:05
Sotera Health Company (SHC) Q4 Earnings Preview: Key Points to Watch
101 finance2026-02-23 03:12:38
Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026
Finviz2026-02-23 13:42:48
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
Finviz2026-02-23 22:15:05
Qualcomm, Booking Holdings receive upgrades: Leading analyst picks from Wall Street
101 finance2026-02-24 14:45:35
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
Finviz2026-02-24 17:33:10
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 21:33:11
Gossamer Bio (GOSS) Reports Topline Phase 3 Results for Seralutinib in Pulmonary Arterial Hypertension
Finviz2026-02-25 10:54:06
Darling Ingredients (NYSE:DAR) Q4 Results: Outperforming in the Ingredients, Flavors & Fragrances Sector
101 finance2026-02-25 13:03:42
N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
Finviz2026-02-25 13:34:28
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
Finviz2026-02-25 13:48:47
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Finviz2026-02-26 12:03:47
Regenxbio (RGNX) Likely to Surpass Earnings Predictions: Will the Share Price Rise?
101 finance2026-02-26 16:04:08
Keros Therapeutics Appoints Charles Newton to its Board of Directors
Finviz2026-02-26 21:03:45
Nexa Resources Reports Adjusted EBITDA of US$772 Million, and US$223 Million Net Income in 2025
Finviz2026-02-26 21:27:03
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
Finviz2026-02-27 19:24:07
BKYI stock chart
BKYI stock detailsBKYI stock price change
On the last trading day, BKYI stock closed at 0.64 USD, with a price change of 3.05% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more